Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Immune X on the Incidence of the Common Cold in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT07787130 is registered in ClinicalTrials.gov with Givaudan France Naturals as lead sponsor.

NCT NCT07787130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07787130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Immune X on the Incidence of the Common Cold in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Givaudan France Naturals
Phase
Not applicable
Overall status
Recruiting
Start date
October 9, 2026
Completion date
March 1, 2027
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common cold, upper respiratory tract infection (urti)